Literature DB >> 6764199

Gardnerella vaginalis and its clinical syndrome.

M J Balsdon.   

Abstract

The Gardnerella vaginalis syndrome is a well defined but benign condition characterized by a smelly vaginal discharge of pH greater than 5.0. It is not associated with inflammation. It often occurs in association with cervical infections. The microscopic appearance of the discharge is typical and diagnostic. The wet mount shows "clue cells" and "rafts" (floating clumps of small bacilli) and the Gram stain has the "pepper on salt" pattern of masses of small gram-variable bacilli. The amine test is an additional diagnostic aid. Cultures are useful but not necessary for diagnosis. The treatment of choice is oral metronidazole 400 mg twice daily for five days.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6764199     DOI: 10.1007/bf02019973

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  19 in total

1.  Epidemiologic characteristics of women infected with Corynebacterium vaginale (Haemophilus vainalis).

Authors:  W E Josey; D W Lambe
Journal:  J Am Vener Dis Assoc       Date:  1976-09

2.  Gardnerella vaginalis, anaerobes, and vaginal discharge.

Authors:  E Taylor; A L Blackwell; D Barlow; I Phillips
Journal:  Lancet       Date:  1982-06-19       Impact factor: 79.321

3.  Vaginal colonization with Corynebacterium vaginale (Haemophilus vaginalis).

Authors:  W M McCormack; C H Hayes; B Rosner; J R Evrard; V A Crockett; S Alpert; S H Zinner
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226

4.  Anaerobic bacteria in nonspecific vaginitis.

Authors:  C A Spiegel; R Amsel; D Eschenbach; F Schoenknecht; K K Holmes
Journal:  N Engl J Med       Date:  1980-09-11       Impact factor: 91.245

5.  Identification of Gardnerella (Haemophilus) vaginalis.

Authors:  P Piot; E Van Dyck; P A Totten; K K Holmes
Journal:  J Clin Microbiol       Date:  1982-01       Impact factor: 5.948

6.  Metronidazole metabolite and Gardnerella vaginalis (Corynebacterium vaginale)

Authors:  M J Baldson; D Jackson
Journal:  Lancet       Date:  1981-05-16       Impact factor: 79.321

Review 7.  Corynebacterium vaginale.

Authors:  W E Dunkelberg
Journal:  Sex Transm Dis       Date:  1977 Apr-Jun       Impact factor: 2.830

8.  Ineffectiveness of erythromycin for treatment of Haemophilus vaginalis-associated vaginitis: possible relationship to acidity of vaginal secretions.

Authors:  M A Durfee; P S Forsyth; J A Hale; K K Holmes
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

Review 9.  Haemophilus vaginalis vaginitis after twenty-five years.

Authors:  H L Gardner
Journal:  Am J Obstet Gynecol       Date:  1980-06-01       Impact factor: 8.661

10.  Relative susceptibilities of Gardnerella vaginalis (Haemophilus vaginalis), Neisseria gonorrhoeae, and Bacteroides fragilis to Metronidazole and its two major metabolites.

Authors:  E D Ralph; Y E Amatnieks
Journal:  Sex Transm Dis       Date:  1980 Oct-Dec       Impact factor: 2.830

View more
  2 in total

1.  In vitro activity of ciprofloxacin and norfloxacin against Gardnerella vaginalis.

Authors:  K Machka
Journal:  Eur J Clin Microbiol       Date:  1984-08       Impact factor: 3.267

2.  Non-volatile fatty acids in the diagnosis of non-specific vaginitis.

Authors:  C A Ison; C S Easmon; S G Dawson; G Southerton; J W Harris
Journal:  J Clin Pathol       Date:  1983-12       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.